Inhibition of the BamHI cleavage and unwinding of pBR322 deoxyribonucleic acid by the antitumor drug cis-dichlorodiammineplatinum(II).
Inhibition of the BamHI cleavage and unwinding of pBR322 deoxyribonucleic acid by the antitumor drug cis-dichlorodiammineplatinum(II).
复制标题
抗肿瘤药物顺式二氯二氨铂 (II) 对 pBR322 脱氧核糖核酸的 BamHI 裂解和解旋的抑制。
DOI:
10.1021/bi00516a012
复制
发表时间:
1981
期刊:
影响因子:
2.9
通讯作者:
Lippard,SJ
中科院分区:
文献类型:
--
作者:
Ushay,HM;Tullius,TD;Lippard,SJ
H. Michael Ushay, Thomas D. Tullius, and Stephen J. Lippard* abstract: The antitumor drug m-dichlorodiammineplatinum (II)(a's-DDP) binds to pBR322 DNA and inhibits the cleavage of this circular DNA into a linear form by the restriction endonuclease BamUl. The binding of platinum to DNA was monitored byagarose gel electrophoresis, and the amount of platinumbound per nucleotide (rb) was measured by carbon rod atomic absorption spectroscopy. Electrophoretic mobility changes reflect a shortening and unwinding of the DNA duplex upon platinum binding as observed previously for the reaction of cis-and frans-DDP with pSMl DNA [Cohen, G. L., Bauer, WR, Barton, J. K., & Lippard, S. J.(1979) Science {Washington, DC) 203, 1014-1016], The inhibition of BamUl nuclease activity occurs at very low binding levels and is complete at/-b= 0.045. This value corresponds to the binding of one platinum atom within±3 base pairs of the recognition sequence of the enzyme shown